Pharmacovigilance: Monitoring and reporting adverse drug reactions

Abstract

Pharmacovigilance plays a pivotal role in ensuring the safety and efficacy of pharmaceutical products by monitoring and reporting adverse drug reactions (ADRs). This research paper delves into the comprehensive understanding of pharmacovigilance systems, emphasizing the importance of monitoring and reporting ADRs in the healthcare ecosystem. Through an extensive review of literature and analysis of case studies, this study elucidates the challenges faced in pharmacovigilance, including underreporting, signal detection, and regulatory frameworks. Furthermore, it explores the evolving methodologies and technologies employed for efficient ADR detection and reporting, such as data mining algorithms and spontaneous reporting systems. The paper also discusses the critical role of healthcare professionals and patients in enhancing pharmacovigilance practices. By shedding light on the significance of proactive surveillance and robust reporting mechanisms, this research contributes to the advancement of pharmacovigilance strategies, thereby promoting drug safety and public health.